6:00 pm ET
This opening cocktail reception experience will welcome our global community of healthcare and cross-sector leaders to kick-off this year’s landmark gathering.
7:00 pm ET
Bioelectronic medicine is on the cusp of reshaping patient treatment. With breakthrough developments across the regulatory, clinical, scientific, and business landscapes, we stand at the threshold of a new era in healthcare. At the forefront of this movement is Northwell’s research arm, The Feinstein Institutes for Medical Research. As we open the 2025 Constellation Forum, President and CEO Kevin Tracey will highlight the forces driving this transformation and set the tone for the days — and the decades — to come.
Kevin Tracey, MD, President and CEO, Feinstein Institutes for Medical Research, Northwell Health
Moderator: Tyler Mathisen, Former Co-Anchor, CNBC’s Power Lunch; Distinguished Fellow, Graham School, University of Chicago
9:00 pm ET
Thank you for joining us at the opening Welcome Experience. See you tomorrow!
8:00 am ET
9:00 am ET
We are standing at the edge of a golden age in medicine. Breakthroughs in precision medicine, GLP-1 therapies, and personalized care hold extraordinary promise for the future of human health. But realizing this potential requires us to think differently about how we adopt, how we adapt, and how we lead change to better the human condition. In this opening address, Northwell Health’s CEO will share how the organization, together with the Feinstein Institutes, is charting a global path forward. The Constellation Forum has become a premier platform for advancing innovation, and this year it highlights a revolution already underway in our own backyard: Bioelectronic Medicine.
John D’Angelo, CEO-Elect, Northwell Health
9:10 am ET
Jill Kalman, MD, Chief Medical Officer, EVP, and Deputy Physician-in-Chief, Northwell Health
9:15 am ET
We are entering a moment of transformation in healthcare. Bioelectronic Medicine, born from scientific discovery and now advanced into clinical application, is poised to deeply change not only how we treat disease, but our society, economy, and culture at large. Kevin Tracey, President and CEO of the Feinstein Institutes for Medical Research, will trace its journey from laboratory to adoption, and share a vision of how this novel therapeutic could eradicate inflammation, extend human healthspan, and redefine the nature of medicine.
Kevin Tracey, MD, President and CEO, Feinstein Institutes for Medical Research, Northwell Health
9:30 am ET
This session will explore how the business, innovation, and scientific communities have come together to develop bioelectronic medicine. We’ll explore why this technology is a good bet for investors and entrepreneurs moving forward, and how can we generate more innovation, R&D, and dealmaking activity in the space.
Peder Olofsson, MD, PhD, Program Director, Bioelectronic Medicine, Karolinska Institutet
Josh Makower, MD, Co-Founder and Director, Stanford Biodesign
Zack Scott, MD, General Partner, Norwest
Amaza Reitmeier, VP and General Manager, Neuromodulation Portfolio and Leader, Global Brain Health Solutions Team, Medtronic
Moderator: Bertha Coombs, Senior Health Care Reporter, CNBC
9:55 am ET
Breakthrough science only fulfills its promise when it reaches patients. This session will examine the critical path to widespread adoption: navigating approvals, building the clinical evidence base, building the business case, and creating the infrastructure to scale globally. Leaders across the field will share what it takes to bring Bioelectronic Medicine into everyday clinical practice, and how to accelerate its journey from the lab to the marketplace.
Ami Bhatt, MD, Chief Innovation Officer, American College of Cardiology; Chair, Digital Health Advisory Committee, FDA
Juan-Pablo Mas, Partner, Action Potential Venture Capital
Moderator: To be announced
10:20 am ET
Pioneering technologies often face their greatest challenges at the edge of adoption. Few understand this better than Dr. Geoffrey Ling, former Director of DARPA’s Biological Technologies Office, serial entrepreneur, and CEO, who has spent his career advancing scientific breakthroughs. In this session, Dr. Ling will reflect on what it means to operate at the bleeding edge of innovation: the hurdles, the opportunities, and the profound stakes for national interests, global progress, and the future of humanity.
Geoffrey Ling, MD, PhD, Former Director, DARPA Biological Technologies Office; Serial Entrepreneur; Chief Executive Officer, Ling and Associates
10:30 am ET
As Bioelectronic Medicine moves from discovery to deployment, the question becomes: how do we integrate it into everyday clinical practice? This session will explore how research breakthroughs, physician training, hospital adoption, and patient advocacy can align to ensure Bioelectronic Medicine addresses urgent, underserved medical needs and drive this paradigm shift in care.
Hubert Lim, PhD, Director of the Earl E. Bakken Medical Devices Center and Professor of Biomedical Engineering and Otolaryngology, University of Minnesota
Leonard Calabrese, DO, Professor of Medicine and Vice Chair of the Department of Rheumatic and Immunologic Diseases, Cleveland Clinic
Amy Rochlin, CEO, Complex Disorders Alliance
Moderator: Daniel Sciubba, MD, Senior Vice President of Neurosurgery, Northwell Health
10:55 am ET
11:25 am ET
Jill Kalman, MD, Chief Medical Officer, EVP, and Deputy Physician-in-Chief, Northwell Health
11:30 am ET
For more than three decades, bold bets on Bioelectronic Medicine have reflected the nation’s spirit of innovation and willingness to push the frontiers of science. Now, as we look to the next 30 years, the question is how to build the ecosystem required to scale these breakthroughs: funding innovation early, fostering adoption, and de-risking investments to ensure lasting success. This session will explore how a continued commitment can solve some of healthcare’s greatest challenges, accelerate clinical impact, and strengthen America’s global leadership.
Scott Rechler, CEO and Chairman, RXR
Murthy Simhambhatla, PhD, President and CEO, SetPoint Medical
Moderator: Cliff Friedman, Managing Director, Head of Northwell Strategic Ventures Group, Northwell Health
11:55 am ET
Bioelectronic Medicine stands to disrupt how we diagnose, treat, and manage disease, but fulfilling that promise requires broad alignment across the healthcare ecosystem. This session will explore how to rally the global community, engage first movers, foster cross-sector collaboration, and bring payors and pharma to the table as allies in driving adoption and impact.
Scott Gottlieb, MD, Former Commissioner, FDA; Partner, New Enterprise Associates
Kristoffer Famm, PhD, President and CEO, Galvani Bioelectronics
Moderator: To be announced
12:20 pm ET
At the core of every breakthrough is a patient in need. This session shares a personal journey of triumph, and highlights why innovation in treatment is essential to bettering the lives of those who entrust us with their care. A powerful reminder of the human stakes driving Bioelectronic Medicine forward.
12:35 pm ET
John D’Angelo, CEO-Elect, Northwell Health
12:45 pm ET
Buffet Lunch, general networking, and themed roundtable discussion groups
2:00 pm ET